Vascular endothelial cells and dysfunctions: Role of melatonin

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 1, 2013, Pages 119-129

  Fabrizio, Rodella Luigi ^a   Gaia, Favero ^a   Eleonora, Foglio ^a   Claudia, Rossini ^a   Stefania, Castrezzati ^a   Claudio, Lonati ^a   Rita, Rezzani ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Endothelium; Melatonin; Nitric oxide; Review

Indexed keywords

MELATONIN; NITRIC OXIDE; NICOTINE;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; NONHUMAN; REPERFUSION INJURY; THROMBOCYTE AGGREGATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; CHEMICALLY INDUCED DISORDER; ENDOTHELIUM CELL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA;

ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; MELATONIN; NICOTINE; REPERFUSION INJURY; VASCULAR DISEASES;

MLCS; MLOWN;

EID: 84877834822     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e601     Document Type: Article

References (149)

1. AP Fishman: Endothelium: a distributed organ of diverse capabilities. Ann N Y Acad Sci 401, 1-8 (1982)
2. BC Douglas, SE Pollak, AC Buck, J Loscalzo, GA Zimmerman, RP McEver, JS Pober, TM Wick, BA Konkle, BS Schwartz, ES Barnathan, KR McCrae, BA Hug, AM Schmidt and DM Stern: Endothelial cells in physiology and in the pathophysiology of vascular disorder. Blood 91, 3527-3561 (1998) (Pubitemid 28225719)
3. AR Pries, TW Secomb and P Gaehtgens: The endothelial surface layer. Pflugers Arch 440, 653-666 (2000)
4. WB Campbell, D Gebremedhin, PF Pratt and DR Harder: Identification of epoxyeicosatrienoic acids as endotheliumderived hyperpolarizing factors. Circ Res 78, 415-423 (1996) (Pubitemid 26072547)
5. D Harris, DA Kendall and MD Randall: Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor. Naunyn Schmiedebergs Arch Pharmacol 359, 48-52 (1999) (Pubitemid 29142569)
6. KA Pasyk and BA Jakobczak: Vascular endothelium: recent advances. Eur J Dermatol 14, 209-213 (2004) (Pubitemid 39024224)
7. EL Schiffrin: A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 38, S3-6 (2001)
8. HR Lijnen and D Collen: Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis 39, 343-350 (1997) (Pubitemid 27120401)
9. T Gori, S Dragoni, G Di Stolfo and S Forconi: Endothelium and haemorheology. Ann Ist Super Sanita 43, 124-129 (2007)
10. S Verma, MR Buchanan and TJ Anderson: Endothelial function testing as a biomarker of vascular disease. Circulation 108, 2054-2059 (2003) (Pubitemid 37337577)
11. KP Minneman and RJ Wurtman: The pharmacology of the pineal gland. Annu Rev Pharmacol Toxicol 16, 33-51 (1976)
12. A Carrillo-Vico, JM Guerrero, PJ Lardone and RJ Reiter: A review of the multiple actions of melatonin on the immune system. Endocrine 27, 189-200 (2005) (Pubitemid 41558451)
13. RJ Reiter, K Li, A Gonzalez-Brito, MG Tannenbaum, MK Vaughan, GM Vaughan and M Villanua: Elevated environmental temperature alters the responses of the reproductive and thyroid axes of female Syrian hamsters to afternoon melatonin injections. J Pineal Res 5, 301-315 (1988)
14. B Claustrat, J Brun and G Chazot: The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9, 11-24 (2005) (Pubitemid 40092915)
15. M Follenius, L Weibel and G Brandenberger: Distinct modes of melatonin secretion in normal men. J Pineal Res 18, 135-140 (1995)
16. N Zisapel: Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci 64, 1174-1186 (2007) (Pubitemid 46791055)
17. N Zisapel: Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 21, 605-616 (2001) (Pubitemid 34538858)
18. M Karasek: Melatonin, human aging, and age-related diseases. Exp Gerontol 39, 1723-1729 (2004) (Pubitemid 39576142)
19. R Salti, F Galluzzi, G Bindi, F Perfetto, R Tarquini, F Halberg and G Cornélissen: Nocturnal melatonin patterns in children. J Clin Endocrinol Metab 85, 2137-2144 (2000) (Pubitemid 32269234)
20. E Grossman, M Laudon, R Yalcin, H Zengil, E Peleg, Y Sharabi, Y Kamari, Z Shen-Orr and N Zisapel: Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 119, 898-902 (2006) (Pubitemid 44415610)
21. DX Tan, LC Manchester, MP Terron, LJ Flores and RJ Reiter: One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42, 28-42 (2007) (Pubitemid 44924323)
22. A Carrillo-Vico, RJ Reiter, PJ Lardone, JL Herrera, R Fernández-Montesinos, JM Guerriero and D Pozo: The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 7, 423-431 (2006) (Pubitemid 43772981)
23. O Nosjean, M Ferro, F Coge, P Beauverger, JM Henlin, F Lefoulon, JL Fauchere, P Delagrange, E Canet and JA Boutin: Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275, 31311-31317 (2000)
24. ML Dubocovich, MA Rivera-Bermudez, MJ Gerdin and MI Masana: Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8, 1093-1108 (2003)
25. DX Tan, LC Manchester, R Hardeland, S Lopez-Burillo, JC Mayo, RM Sainz and RJ Reiter: Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 34, 75-78 (2003)
26. SS Du Plessis, K Hagenaar and F Lampiao: The in vitro effects of melatonin on human sperm function and its scavenging activities on NO and ROS. Andrologia 42, 112-116 (2010)
27. IB Zavodnik, AV Domanski, EA Lapshina, M Bryszewska and RJ Reiter: Melatonin directly scavenges free radicals generated in red blood cells and a cell-free system: chemiluminescence measurements and theoretical calculations. Life Sci 79, 391-400 (2006) (Pubitemid 43833367)
28. R Hardeland, C Backhaus, A Fadavi and M Hess: N (1) - acetyl-5-methoxykynuramine contrasts with other tryptophan metabolites by a peculiar type of NO scavenging: cyclization to a cinnolinone prevents formation of unstable nitrosamines. J Pineal Res 43, 104-105 (2007) (Pubitemid 47035215)
29. R Rezzani, LF Rodella, F Bonomini, S Tengattini, R Bianchi, RJ Reiter: Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 41, 288-295 (2006) (Pubitemid 44337727)
30. VK Bearti and RS Srivastava: Pineal proteins upregulate specific antioxidant defense systems in the brain. Oxid Med Cell Longev 2, 88-92 (2009)
31. MJ Jou, TI Peng, PZ Yu, SB Jou, RJ Reiter, JY Chen, HY Wu, CC Chen and LF Hsu: Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 43, 389-403 (2007) (Pubitemid 47512271)
32. RJ Reiter, DX Tan and A Korkmaz: The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens Suppl 27, S17-20 (2009)
33. M Broncel, M Koziróg-Kołaciñska and J Chojnowska-Jezierska: Melatonin in the treatment of atherosclerosis. Pol Merkur Lekarski 23, 124-127 (2007)
34. T Ravindra, NK Lakshmi and YR Ahuja: Melatonin in pathogenesis and therapy of cancer. Indian J Med Sci 60, 523-535 (2006) (Pubitemid 44935001)
35. RJ Reiter, DX Tan, J Leon, U Kilic, E Kilic: When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) 230, 104-117 (2005)
36. SD Skaper, M Floreani, M Ceccon, L Facci, P Giusti: Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann N Y Acad Sci 890, 107-118 (1999) (Pubitemid 30040369)
37. RJ Reiter, JM Guerrero, JJ Garcia, D Acuna-Castroviejo: Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci 854, 410-424 (1998)
38. F Radogna, M Diederich and L Ghibelli: Melatonin: a pleiotropic molecole regulating inflammation. Biochem Pharmacol 80, 1844-1852 (2010)
39. RA Cohen and X Tong: Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 55, 308-316 (2010)
40. S Moncada and EA Higgs: Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 213-254 (2006)
41. Y Kitta, JE Obata, T Nakamura, M Hirano, Y Kodama, D Fujioka, Y Saito, K Kawabata, K Sano, T Kobayashi, T Yano, K Nakamura and K Kugiyama: Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 53, 323-330 (2009)
42. K Dharmashankar and ME Widlansky: Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12, 448-455 (2010)
43. L Paulis, O Pechanova, J Zicha, S Liskova, P Celec, M Mullerova, J Kollar, M Behuliak, J Kunes, M Adamcova and F Simko: Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment. J Hypertens 28(S1), 19-24 (2010)
44. RR Tunstall, P Shukla, A Grazul-Bilska, C Sun and ST O'Rourke: MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries. J Pharmacol Exp Ther 336, 127-133 (2011)
45. ML Dubocovich: Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16, 50-56 (1995)
46. MI Masana, S Doolen, C Ersahin, WM Al-Ghoul, SP Duckles, ML Dubocovich and DN Krause: MT (2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302, 1295-1302 (2002) (Pubitemid 34920255)
47. L Pogan, P Bissonnette, L Parent and R Sauvé: The effects of melatonin on Ca (2+) homeostasis in endothelial cells. J Pineal Res 33, 37-47 (2002) (Pubitemid 34833073)
48. F Simko and L Paulis: Melatonin as a potential antihypertensive treatment. J Pineal Res 42, 319-322 (2007) (Pubitemid 46581667)
49. EA Kowaluk, P Seth and HL Fung: Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262, 916-922 (1992)
50. LJ Ignarro, H Lippton, JC Edwards, WH Baricos, AL Hyman, PJ Kadowitz and CA Gruetter: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218, 739-749 (1981) (Pubitemid 11005147)
51. F Murad: Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78, 1-5 (1986) (Pubitemid 16068173)
52. A Sakotnik, PM Liebmann, K Stoschitzky, P Lercher, K Schauenstein, W Klein and B Eber: Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 20, 1314-1317 (1999) (Pubitemid 29429717)
53. A Domínguez-Rodríguez, P Abreu-González, MJ García, J Sanchez, F Marrero and D de Armas-Trujillo: Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 33, 248-252 (2002) (Pubitemid 35252997)
54. L Paulis, O Pechanova, J Zicha, S Liskova, P Celec, M Mullerova, J Kollar, M Behuliak, J Kunes, M Adamcova and F Simko: Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of LNAME treatment. J Hypertens 28, S19-24 (2010)
55. ME Widlansky, N Gokce, JF Keaney Jr and JA Vita: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42, 1149-1160 (2003) (Pubitemid 37188333)
56. A Púzserová, J Kopincová and I Berná tová: Endothelial (dys) function in the experimental model of primary hypertension. Cesk Fysiol 59, 4-14 (2010)
57. D Rizzoni, C De Ciuceis, E Porteri, F Semeraro and EA Rosei: Structural Alterations of Small Resistance Arteries in Obesity. Basic Clin Pharmacol Toxicol [Epub ahead of print] (2011)
58. TJ Kizhakekuttu and ME Widlansky: Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther 28, e20-32 (2010)
59. S Tengattini, RJ Reiter, DX Tan, MP Terron, LF Rodella and R Rezzani: Cardiovascular diseases: protective effects of melatonin. J Pineal Res 44, 16-25 (2008) (Pubitemid 350231106)
60. F Simko and O Pechanova: Remodelling of the heart and vessels in experimental hypertension: advances in protection. J Hypertens 28, S1-6 (2010)
61. RM Touyz and EL Schiffrin: Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122, 339-352 (2004) (Pubitemid 39506592)
62. RA Jacob and BJ Burri: Oxidative damage and defense. Am J Clin Nutr 63, 985S-990S (1996) (Pubitemid 26172390)
63. M Nava, Y Quiroz, N Vaziri and B Rodriguez-Iturbe: Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284, 447-454 (2003)
64. RM Touyz: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252 (2004) (Pubitemid 39167216)
65. MA Newaz and NN Nawal: Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 11, 1480-1485 (1998) (Pubitemid 29030314)
66. R Rezzani, E Porteri, C De Ciuceis, F Bonomini, LF Rodella, S Paiardi, GE Boari, C Platto, A Pilu, D Avanzi, D Rizzoni and E Agabiti Rosei: Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension 55, 1373-1380 (2010)
67. L Paulis and F Simko: Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiol Res 56, 671-684 (2007)
68. F Simko and L Paulis: Melatonin as a potential antihypertensive treatment. J Pineal Res 42, 319-322 (2007) (Pubitemid 46581667)
69. S Arangino, A Cagnacci, M Angiolucci, AM Vacca, G Longu, A Volpe and GB Melis: Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 83, 1417-1419 (1999) (Pubitemid 29205758)
70. R Das, L Balonan, HJ Ballard and S Ho: Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery. Int J Cardiol 126, 340-345 (2008) (Pubitemid 351637632)
71. RJ Reiter, DX Tan, SD Paredes and L Fuentes-Broto: Beneficial effects of melatonin in cardiovascular disease. Ann Med 42, 276-285 (2010)
72. H Girouard and J de Champlain: Inhibitory effect of melatonin on alpha1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens 17, 339-346 (2004) (Pubitemid 38446849)
73. E Sewerynek: Melatonin and the cardiovascular system. Neuro Endocrinol Lett 23(S1), 79-83 (2002) (Pubitemid 34495387)
74. F Simko and O Pechanova: Recent trends in hypertension treatment: perspectives from animal studies. J Hypertens Suppl 27, S1-4 (2009)
75. RJ Reiter, SD Paredes, LC Manchester and DX Tan: Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44, 175-200 (2009)
76. M. M. Anwar, A. R. Meki and H. H. Rahma: Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators. Comp Biochem Physiol C Toxicol Pharmacol 130, 357-367 (2001) (Pubitemid 33043708)
77. CF Reyes-Toso, D Obaya-Naredo, CR Ricci, FM Planells, JE Pinto, LM Linares and DP Cardinali: Effect of melatonin on vascular responses in aortic rings of aging rats. Exp Gerontol 42, 337-342 (2007) (Pubitemid 46356843)
78. CF Reyes-Toso, MI Rosón, LE Albornoz, PF Damiano, LM Linares and DP Cardinali: Vascular reactivity in diabetic rats: effect of melatonin. J Pineal Res 33, 81-86 (2002) (Pubitemid 34913484)
79. CF Reyes-Toso, LM Linares, CR Ricci, M Arán, JE Pinto, RR Rodríguez and DP Cardinali: Effect of melatonin on vascular reactivity in pancreatectomized rats. Life Sci 74, 3085-3092 (2004) (Pubitemid 38470101)
80. CF Reyes-Toso, LM Linares, CR Ricci, D Obaya-Naredo, JE Pinto, RR Rodríguez and DP Cardinali: Melatonin restores endothelium-dependent relaxation in aortic rings of pancreatectomized rats. J Pineal Res 39, 386-391 (2005)
81. GR De Meyer and AG Herman: Vascular endothelial dysfunction. Prog Cardiovasc Dis 39, 325-342 (1997) (Pubitemid 27120400)
82. K Kawashima, Y Miwa, K Fujimoto, H Oohata, H Nishino and H Koike: Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens A9, 1121-1131 (1987)
83. O Pechánová, J Zicha, L Paulis, W Zenebe, Z Dobesová, S Kojsová, L Jendeková, M Sládková, I Dovinová, F Simko and J Kunes: The effect of Nacetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 561, 129-136 (2007) (Pubitemid 46435853)
84. F Simko and J Simko: The potential role of nitric oxide in the hypertrophic growth of the left ventricle. Physiol Res 49, 37-46 (2000) (Pubitemid 30111295)
85. F Simko, I Luptak, J Matuskova, K Krajcirovicova, Z Sumbalova, J Kucharska, A Gvozdjakova, J Simko, P Babal, O Pechanova and I Bernatova: L-arginine fails to protect against myocardial remodelling in L-NAMEinduced hypertension. Eur J Clin Invest 35, 362-368 (2005) (Pubitemid 40826834)
86. Z Kurcer, E Sahna and E Olmez: Vascular reactivity to various vasoconstrictor agents and endothelium-dependent relaxations of rat thoracic aorta in the long-term period of pinealectomy. J Pharmacol Sci 101, 329-334 (2006) (Pubitemid 44285181)
87. A Zanoboni, A Forni, W Zanoboni-Muciaccia, C Zanussi: Effect of pinealectomy on arterial blood pressure and food and water intake in the rat. J Endocrinol Invest 1, 125-130 (1978) (Pubitemid 9100769)
88. HJ Harlow: Influence of the pineal gland and melatonin on blood flow and evaporative water loss during heat stress in rats. J Pineal Res 4, 147-159 (1987) (Pubitemid 17063089)
89. K Kedziora-Kornatowska, K Szewczyk-Golec, J Czuczejko, H Pawluk, K van Marke de Lumen, M Kozakiewicz, G Bartosz and J Kedziora: Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res 45, 312-317 (2008)
90. E Walters-Laporte, C Furman, S Fouquet, F Martin-Nizard, S Lestavel, A Gozzo, D Lesieur, JC Fruchart, P Duriez and E Teissier: A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells. J Cardiovasc Pharmacol 32, 582-592 (1998) (Pubitemid 28440959)
91. K Vijayasarathy, K Shanthi Naidu and BK Sastry: Melatonin metabolite 6-Sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina. Int J Cardiol 144, 315-317 (2010)
92. ML Pita, M Hoyos, I Martin-Lacave, C Osuna, JM Fernández-Santos and JM Guerrero: Long-term melatonin administration increases polyunsaturated fatty acid percentage in plasma lipids of hypercholesterolemic rats. J Pineal Res 32, 179-186 (2002) (Pubitemid 34309885)
93. HQ Zhu, XW Cheng, LL Xiao, ZK Jiang, Q Zhou, SY Gui, W Wei and Y Wang: Melatonin prevents oxidized low-density lipoprotein-induced increase of myosin light chain kinase activation and expression in HUVEC through ERK/MAPK signal transduction. J Pineal Res 45, 328-334 (2008)
94. SY Yuan, MH Wu, EE Ustinova, M Guo, JH Tinsley, P De Lanerolle and W Xu: Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res 90, 1214-1221 (2002) (Pubitemid 34786907)
95. WE Stehbens: An appraisal of cholesterol feeding in experimental atherogenesis. Prog Cardiovasc Dis 29, 107-128 (1986) (Pubitemid 16003136)
96. A Wakatsuki, Y Okatani, N Ikenoue, K Shinohara, K Watanabe and T Fukaya: Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery. J Pineal Res 31, 281-288 (2001) (Pubitemid 32905239)
97. K Paskaloglu, G Sener and G Ayanoolu-Dülger: Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 499, 345-354 (2004) (Pubitemid 39233674)
98. A Flyvbjerg: Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43, 1205-1223 (2000)
99. FM Ho, SH Liu, CS Liau, PJ Huang and SY Lin-Shiau: High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun. NH (2)-terminal kinase and caspase-3. Circulation 101, 2618-2624 (2000) (Pubitemid 30350641)
100. Y Ido, D Carling and N Ruderman: Hyperglycemiainduced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51, 159-167 (2002) (Pubitemid 34517993)
101. E Favaro, I Miceli, B Bussolati, M Schmitt-Ney, P Cavallo Perin, G Camussi and MM Zanone: Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway. Am J Pathol 173, 442-450 (2008)
102. P Langenstroer and GM Pieper: Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 263, H257-265 (1992)
103. L Rodríguez-Mañas, J Angulo, C Peiró, JL Llergo, A Sánchez-Ferrer, P López-Dóriga and CF Sánchez- Ferrer: Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 123, 1495-1502 (1998) (Pubitemid 28182030)
104. PL Montilla, JF Vargas, IF Túnez, MC Muñoz de Agueda, ME Valdelvira and ES Cabrera: Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 25, 94-100 (1998) (Pubitemid 28392105)
105. BD Keavney, CR Dudley, IM Stratton, RR Holman, DR Matthews, PJ Ratcliffe and RC Turner: UK prospective diabetes study (UKPDS) 14: association of angiotensinconverting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38, 948-952 (1995)
106. MR Taskinen: Type 2 diabetes as a lipid disorder. Curr Mol Med 5, 297-308 (2005)
107. KM Azadzoi and I Saenz de Tejada: Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 148, 1587-1591 (1992)
108. IA van den Oever, HG Raterman, MT Nurmohamed and S Simsek: Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010:792393 Epub 2010 Jun. 15 (2010)
109. JA Kim, M Montagnani, KK Koh and MJ Quon: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904 (2006) (Pubitemid 43739401)
110. JJ Strain: Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 50, 591-604 (1991)
111. D Giugliano, A Ceriello and G Paolisso: Oxidative stress and diabetic vascular complications. Diabetes Care 19, 257-267 (1996) (Pubitemid 26070354)
112. TJ Guzik, S Mussa, D Gastaldi, J Sadowski, C Ratnatunga, R Pillai and KM Channon: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (P) H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-1662 (2002) (Pubitemid 34298608)
113. NR Madamanchi, A Vendrov and MS Runge: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25, 29-38 (2005) (Pubitemid 40054251)
114. G Baydas, H Canatan and A Turkoglu: Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 32, 225-230 (2002) (Pubitemid 34478283)
115. H Vural, T Sabuncu, SO Arslan and N Aksoy: Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res 31, 193-198 (2001) (Pubitemid 32905227)
116. MM Sailaja Devi and Y Suresh: Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 29, 108-115 (2000)
117. J Calles-Escandon and M Cipolla: Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22, 36-52 (2001) (Pubitemid 32187802)
118. E Peschke: Melatonin, endocrine pancreas and diabetes. J Pineal Res 44, 26-40 (2008) (Pubitemid 350231107)
119. C Sartori, P Dessen, C Mathieu, A Monney, J Bloch, P Nicod, U Scherrer and H Duplain: Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 150, 5311-5317 (2009)
120. R Muniyappa, M Montagnani, KK Koh and MJ Quon: Cardiovascular actions of insulin. Endocr Rev 28, 463-491 (2007) (Pubitemid 47236334)
121. HJ Brömme, H Ebelt, D Peschke and E Peschke: Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin. Cell Mol Life Sci 55, 487-493 (1999) (Pubitemid 29178887)
122. A Armagan, E Uz, HR Yilmaz, S Soyupek, T Oksay and N Ozcelik: Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin- induced diabetic rat testis. Asian J Androl 8, 595-600 (2006) (Pubitemid 44263433)
123. HG Bohlen and JM Lash: Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 265, H219-225 (1993) (Pubitemid 23224713)
124. SC Cunnane, MS Manku, M Oka and DF Horrobin: Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Can J Physiol Pharmacol 58, 287-293 (1980) (Pubitemid 10135051)
125. I Wakabayashi, K Hatake, N Kimura, E Kakishita and K Nagai: Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 40, 643-648 (1987) (Pubitemid 17007150)
126. AD Lopez and CC Murray: The global burden of disease, 1990-2020. Nat Med 4, 1241-1243 (1998) (Pubitemid 28512100)
127. Z Pei and RT Cheung: Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model. J Pineal Res 37, 85-91 (2004) (Pubitemid 39120211)
128. C Mésenge, I Margaill, C Verrecchia, M Allix, RG Boulu and M Plotkine: Protective effect of melatonin in a model of traumatic brain injury in mice. J Pineal Res 25, 41-46 (1998) (Pubitemid 28319915)
129. S Cuzzocrea, G Costantino, E Mazzon, A Micali, A De Sarro and AP Caputi: Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 28, 52-63 (2000) (Pubitemid 30066053)
130. T Fujimoto, T Nakamura, T Ikeda and K Takagi: Potent protective effects of melatonin on experimental spinal cord injury. Spine (Phila Pa 1976) 25, 769-775 (2000) (Pubitemid 30214962)
131. EW Gertz: Cardiomyopathic Syrian hamster: a possible model of human disease. Prog Exp Tumor Res 16, 242-260 (1972)
132. A Colantuoni, G Coppini and S Bertuglia: Capillary density and leukocyte adhesion in hamsters with hereditary cardiomyopathy. Microvasc Res 56, 85-94 (1998) (Pubitemid 28460782)
133. S Bertuglia and RJ Reiter: Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J Pineal Res 42, 55-63 (2007) (Pubitemid 44924326)
134. PR Hansen: Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91, 1872-1885 (1995)
135. YM Lee, HR Chen, G Hsiao, JR Sheu, JJ Wang and MH Yen: Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 33, 72-80 (2002) (Pubitemid 34913483)
136. S Bertuglia, PL Marchiafava and A Colantuoni: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31, 947-952 (1996) (Pubitemid 26188990)
137. R Michael Pittilo: Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol 81, 219-230 (2000)
138. V Nicita-Mauro, C Lo Balbo, A Mento, C Nicita-Mauro, G Maltese and G Basile: Smoking, aging and the centenarians. Exp Gerontol 43, 95-101 (2008)
139. MM Rahman and I Laher: Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 5, 276-292 (2007)
140. S Kilaru, SG Frangos, AH Chen, D Gortler, AK Dhadwal, O Araim and BE Sumpio: Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 193, 538-546 (2001) (Pubitemid 33043458)
141. MM Rahman, S Elmi, TK Chang, N Bai, NA Sallam, VS Lemos, F Moien-Afshari and I Laher: Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release. Vascul Pharmacol 46, 35-42 (2007) (Pubitemid 44856375)
142. K Noma, C Goto, K Nishioka, K Hara, M Kimura, T Umemura, D Jitsuiki, K Nakagawa, T Oshima, K Chayama, M Yoshizumi and Y Higashi: Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 25, 2630-2635 (2005) (Pubitemid 43732289)
143. SM Zemse, RH Hilgers, GB Simkins, RD Rudic and RC Webb: Restoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings. Can J Physiol Pharmacol 86, 557-565 (2008)
144. A Skalska, J Gasowski and T Grodzicki: Antioxidants modify the relationship between endothelin-1 level and glucose metabolism-associated parameters. Metabolism 58, 1229-1233 (2009)
145. LF Rodella, G Favero, C Rossini, E Foglio, RJ Reiter and R Rezzani: Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. Life Sci 87, 558-564 (2010)
146. RJ Reiter, JR Calvo, M Karbownik, W Qi and DX Tan: Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917, 376-386 (2000)
147. E Thorin: Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholineinduced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38, 90-98 (2001) (Pubitemid 32634993)
148. S Pradhan and B Sumpio: Molecular and biological effects of hemodynamics on vascular cells. Front Biosci 9, 3276-3285 (2004)
149. LF Rodella, F Filippini, F Bonomini, R Bresciani, RJ Reiter and R Rezzani: Beneficial effects of melatonin on nicotine-induced vasculopathy. J Pineal Res 48, 126-132 (2010)